by Pharma blister packaging provides a convenient and effective way of packaging pharmaceutical products ranging from tablets and capsules to ointments and creams. Blister packaging offers product protection and ensures the medicinal integrity of drugs. It provides product visibility and clarity of dosage through innovative packaging solutions. Blister packaging improves patient compliance by incorporating calendar packs and dose reminders.
The global Pharma Blister Packaging Market is estimated to be valued at US$ 8.5 billion in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends driving growth in the pharma blister packaging market is the increasing demand for specialized and personalized blister packs. Many pharmaceutical companies are offering customized blister packaging solutions to accommodate specific products and dosage requirements. Specialized blisters designed for inhalers, liquids, syringes and other complex drug delivery formats are witnessing high demand. Adoption of smart and interactive blister foils is another trend emerging in the market. These “smart blisters” incorporate printed electronics that can track medication usage and alert patients and caregivers about missed dosages. They offer enhanced convenience and help improve patient engagement and compliance. Development of eco-friendly blister packaging materials made from recycled, recyclable or biodegradable substances is also gaining traction among pharma manufacturers focusing on sustainability.
Porter’s Analysis
- Threat of new entrants: The threat of new entrants to the pharma blister packaging market is moderate. Pharma blister packaging requires significant investments in machinery and equipment for packaging.
- Bargaining power of buyers: The bargaining power of buyers is high due to presence of many regional and global players offering pharma blister packaging products.
- Bargaining power of suppliers: The bargaining power of suppliers is moderate due to availability of substitutes and undifferentiated products.
- Threat of new substitutes: The threat of new substitutes is moderate as alternative packaging like pouches, bags are used for certain drugs but blisters are preferred for most pharmaceutical products.
- Competitive rivalry: The competition is high among pharma blister packaging suppliers as they continually invest in newer packaging technologies and product differentiation.
Key Takeaways
The global pharma blister packaging market is expected to witness high growth. The global Pharma Blister Packaging Market is estimated to be valued at US$ 8.5 billion in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030.
Asia Pacific region dominated the market and is expected to grow at fastest CAGR during the forecast period due to expansion of pharmaceutical industry and increasing generic drug production in India and China.
Key players related content comprises Key players operating in the pharma blister packaging market are Amcor, Bemis Company, MeadWestvaco Corporation, Rohrer Corporation, Sonoco Products Company, Constantia Flexibles GmbH, Honeywell International, Klockner Pentaplast Group.
